tryptophan has been researched along with celastrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, G; Lu, F; Lv, L; Qi, Y; Wang, R; Yan, H; Zhang, T; Zhao, L; Zhou, F | 1 |
| Chen, X; Fu, Y; Gong, T; Han, X; Hu, Y; John Kao, W; Wang, M; Xu, Y; Zhang, ZR | 1 |
2 other study(ies) available for tryptophan and celastrol
| Article | Year |
|---|---|
Celastrol Suppresses Tryptophan Catabolism in Human Colon Cancer Cells as Revealed by Metabolic Profiling and Targeted Metabolite Analysis.
Topics: Antineoplastic Agents; Cell Survival; Colonic Neoplasms; HCT116 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Metabolomics; Pentacyclic Triterpenes; Triterpenes; Tryptophan | 2018 |
Hierarchical assembly of hyaluronan coated albumin nanoparticles for pancreatic cancer chemoimmunotherapy.
Topics: Albumins; Animals; Cell Line, Tumor; Coated Materials, Biocompatible; Female; Humans; Hyaluronic Acid; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Nanoparticles; Neoplasm Proteins; Pancreatic Neoplasms; Pentacyclic Triterpenes; Triterpenes; Tryptophan; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2019 |